Be Among the First to Tour Our New Website!
Our first major milestone of 2016 is the launch of our brand new website! Redesigning our website has been both a strategic and soul-searching exercise that we have done all for you.
The Union for International Cancer Control (UICC) has been hosting the World Cancer Congress each year since 1933. This year it was held in Malaysia – the first time in South East Asia.

Thousands of delegates from around the world convened in Kuala Lumpur, “to unite the cancer community, reduce the global cancer burden, promote greater equity and integrate cancer into the world’s health and development agenda.”
The Max Foundation was an active participant:

Side-by-side with other internationally recognized leaders, Pat Garcia-Gonzalez, CEO, shared Max’s 20-year-history in “Uncovering the Stories Behind the Leaders.”

Erin Schwartz, VP of Global Engagement, presented on the importance of including patient perspectives in “Global Equity of Cancer Care.”

Ong Mei Ching, Region Head Asia Pacific, conveyed the importance of patient-centricity in “Best Practice Patient Advocacy in Asia Pacific.”

We attended the World Cancer Congress to raise awareness for our core mission – access to cancer treatment – and how to achieve it through our patient-centered model, Max Access Solutions.
We ran an interactive booth, where attendees made video recordings of their own answers to the question: what does treatment access mean to you?
We have received overwhelming responses from key members of the UICC, counterpart organizations, cancer survivors, advocates, doctors, and healthcare providers.

At this prestigious event – empowered by more than 3,000 leaders, cancer and health experts from 139 countries, and more than 85 years of history – our own Pat Garcia-Gonzalez was honored with the CEO Award. The award was given in recognition of The Max Foundation’s leadership and drive to mobilize people and build partnerships across sectors and borders, transforming a grassroots organization into an international movement impacting the tens of thousands of lives worldwide.
Below are some of the quotes we received:




“Cancer patients in the US, in Europe, in Asia, in Nigeria are the same cancer patients. The only difference is where they live. The advocacy should get through to everyone and the treatment should be affordable to everyone.”
Mr. Runcie C. W. Chidebe, Winner of World Cancer Day Spirit Award of UICC; Executive Director of Project PINK BLUE – Health & Psychological Trust Centre, Nigeria

“I have been following The Max Foundation through the website. Max has done great works in giving support to individuals living with cancer. How do I describe Max in one word? Passionate!”
Dr. Hadi Mohamad Abu Rasheed, Head of Professional Development and Scientific Research of Qatar Cancer Society, Qatar

“The Max Foundation is extraordinary and courageous despite the difficult environment. There are not many organization that can provide such niche supports to cancer communities. I would like to explore the opportunity of collaborating with Max to bring more benefits to cancer patients in Nigera.”
Professor Sani Abubakar Malami, President and CEO of Nigerian Cancer Society, Nigeria

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

The journey from experiencing the first symptoms of chronic myeloid leukemia (CML) to finding an effective treatment can be long, difficult, and painful, especially in low- and middle-income countries. That was the case for Chamu from Harare, Zimbabwe. It took him more than a year to get a diagnosis, but he kept fighting and is….

A “cold-chain” product must remain within a specific temperature range at all times. On days- or weeks-long international shipments, it’s especially challenging (and expensive) to keep medicine at a constant temperature. Despite the inherent challenges, adding cold-chain capability is well worth the effort for the patients we support. By doing so, The Max Foundation will be able to better meet the needs of patients who are unresponsive to tablet therapies.